↓ Skip to main content

Gemigliptin, a novel dipeptidyl peptidase 4 inhibitor: first new anti-diabetic drug in the history of Korean pharmaceutical industry

Overview of attention for article published in Archives of Pharmacal Research, June 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

blogs
1 blog
patent
2 patents

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
40 Mendeley